HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giovanni Martinelli Selected Research

Juvenile Polyposis with Hereditary Hemorrhagic Telangiectasia

6/2013Recurrent Gastrointestinal Hemorrhage in Treatment with Dasatinib in a Patient Showing SMAD4 Mutation with Acute Lymphoblastic Leukemia Philadelphia Positive and Juvenile Polyposis Hereditary Hemorrhagic Telangiectasia Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giovanni Martinelli Research Topics

Disease

101BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2021 - 03/2002
96Neoplasms (Cancer)
10/2022 - 07/2002
69Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 05/2002
56Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2022 - 04/2004
35Philadelphia Chromosome
01/2022 - 07/2002
32Multiple Myeloma
04/2022 - 10/2002
32Leukemia
01/2022 - 11/2006
23Hematologic Neoplasms (Hematological Malignancy)
04/2022 - 06/2004
19Lymphoma (Lymphomas)
04/2022 - 01/2003
17Residual Neoplasm
10/2021 - 12/2006
15Infections
01/2021 - 10/2003
13Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2019 - 05/2007
11Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2020 - 06/2002
10Breast Neoplasms (Breast Cancer)
01/2022 - 09/2002
10Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2017 - 06/2004
8Febrile Neutropenia
11/2021 - 10/2007
8Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020 - 07/2007
8Blast Crisis (Blast Phase)
08/2017 - 06/2005
7Disease Progression
01/2022 - 07/2011
7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2021 - 09/2008
6COVID-19
05/2021 - 01/2020
6Thrombocytopenia (Thrombopenia)
10/2019 - 09/2004
6Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
06/2017 - 10/2003
5Genomic Instability
04/2022 - 06/2003
5Neoplasm Metastasis (Metastasis)
01/2020 - 09/2002
5Acute Promyelocytic Leukemia
11/2019 - 04/2003
5Pathologic Complete Response
09/2011 - 10/2005
5Cardiotoxicity
05/2010 - 08/2005
4Neutropenia
11/2021 - 09/2004
4B-Cell Lymphoma (Lymphoma, B Cell)
07/2014 - 10/2003
4Hypereosinophilic Syndrome (Loeffler Endocarditis)
04/2008 - 02/2004
3Hypoxia (Hypoxemia)
01/2022 - 04/2014
3Plasmacytoma
01/2022 - 01/2020
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 08/2010
3Body Weight (Weight, Body)
01/2021 - 10/2014

Drug/Important Bio-Agent (IBA)

77Imatinib Mesylate (Gleevec)FDA Link
01/2021 - 03/2003
50Tyrosine Kinase InhibitorsIBA
01/2022 - 03/2004
22Proteins (Proteins, Gene)FDA Link
06/2022 - 06/2003
21Phosphotransferases (Kinase)IBA
01/2021 - 06/2005
19Rituximab (Mabthera)FDA Link
08/2020 - 10/2003
16nilotinibFDA Link
01/2021 - 06/2007
15Pharmaceutical PreparationsIBA
01/2021 - 01/2004
14Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2021 - 06/2003
14Dasatinib (BMS 354825)FDA Link
01/2021 - 11/2006
12Biological ProductsIBA
04/2022 - 05/2010
12Cytarabine (Cytosar-U)FDA LinkGeneric
01/2022 - 09/2002
10Monoclonal AntibodiesIBA
03/2021 - 06/2002
9DNA (Deoxyribonucleic Acid)IBA
09/2021 - 12/2008
8Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2009
8bcr-abl Fusion ProteinsIBA
09/2013 - 06/2003
8Interferon-alpha (Interferon Alfa)IBA
08/2010 - 03/2002
7AntigensIBA
10/2022 - 04/2016
7ponatinibIBA
01/2022 - 10/2013
6Lenalidomide (CC 5013)FDA Link
01/2022 - 01/2020
6fms-Like Tyrosine Kinase 3IBA
01/2022 - 10/2019
6Inotuzumab OzogamicinIBA
01/2022 - 08/2016
6blinatumomabIBA
11/2021 - 06/2017
6Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2021 - 08/2003
6Gemtuzumab (Mylotarg)FDA Link
09/2021 - 09/2004
6LigandsIBA
03/2021 - 12/2005
6Azacitidine (5 Azacytidine)FDA Link
01/2021 - 08/2009
5EverolimusFDA Link
06/2022 - 02/2010
5Chimeric Antigen ReceptorsIBA
01/2022 - 10/2019
5Messenger RNA (mRNA)IBA
10/2021 - 07/2002
5Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 09/2013
5quizartinibIBA
01/2021 - 01/2018
5Protein Isoforms (Isoforms)IBA
01/2021 - 07/2005
5EnzymesIBA
01/2021 - 09/2007
5Chlorambucil (Leukeran)FDA Link
06/2017 - 10/2003
4SteroidsIBA
01/2022 - 05/2007
4RG7388IBA
01/2022 - 01/2016
4Filgrastim (Neupogen)FDA Link
11/2021 - 01/2006
4Proteasome InhibitorsIBA
03/2021 - 01/2013
4Immune Checkpoint InhibitorsIBA
02/2021 - 01/2019
4Bortezomib (Velcade)FDA Link
12/2020 - 03/2016
4Etoposide (VP 16)FDA LinkGeneric
07/2020 - 10/2005
4CateninsIBA
10/2017 - 09/2013
4Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
04/2008 - 01/2003
3Sirolimus (Rapamycin)FDA Link
06/2022 - 12/2012
3gilteritinibIBA
01/2022 - 10/2019
3MicroRNAs (MicroRNA)IBA
01/2022 - 06/2011
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 08/2020
3Antineoplastic Agents (Antineoplastics)IBA
11/2021 - 01/2018
3pegfilgrastim (Neulasta)FDA Link
11/2021 - 12/2010
3AnthracyclinesIBA
09/2021 - 01/2006
3glasdegibIBA
07/2021 - 08/2015
3Immunomodulating AgentsIBA
03/2021 - 12/2020
3Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2021 - 01/2020
3Thalidomide (Thalomid)FDA Link
09/2020 - 09/2013

Therapy/Procedure

103Therapeutics
10/2022 - 07/2002
53Drug Therapy (Chemotherapy)
01/2022 - 09/2002
23Stem Cell Transplantation
01/2021 - 09/2003
7Immunotherapy
02/2021 - 04/2016
6Autologous Transplantation
12/2020 - 09/2003
5Transplantation
12/2020 - 11/2011
4Radiotherapy
01/2021 - 06/2009
4Hematopoietic Stem Cell Transplantation
01/2021 - 05/2013
4Salvage Therapy
01/2019 - 09/2007
3Drug Tapering
11/2021 - 10/2007
3Homologous Transplantation
01/2021 - 10/2013